Background
Methods
Patient information, data collection, and definitions
Laboratory investigations
Statistical analysis
Results
Subjects’ characteristics and short corticotropin stimulation test
Hospital survivors (n = 12) | Hospital nonsurvivors (n = 34) |
p value | |
---|---|---|---|
Age (years) | 47.6 ± 14.8 | 58.8 ± 14.3 | 0.029 |
Gender (M/F) | 11/1 | 25/9 | 0.252 |
SOFA score | 8.3 ± 2.5 | 14.0 ± 3.6 | <0.001 |
MELD score | 20.9 ± 10.7 | 33.0 ± 9.9 | 0.001 |
Child–Pugh score | 10 (7.3–11.8) | 12 (11–13.3) | 0.005 |
ACTH (pg/ml) | 8.7 (7.5–25.5) | 20.7 (13.1–35.1) | 0.084 |
Baseline cortisol (nmol/L) | 484 (381–796) | 821 (508–1312) | 0.026 |
Peak cortisol (nmol/L) | 955 (633–1258) | 993 (807–1549) | 0.354 |
Cortisol increment (nmol/L) | 359 (257–428) | 200 (110–252) | 0.011 |
Baseline DHEAS (nmol/L) | 1099 (787–2627) | 622 (403–1006) | 0.002 |
Peak DHEAS (nmol/L) | 1286 (1118–2874) | 699 (429–1115) | <0.001 |
DHEAS increment (nmol/L) | 236 (179–391) | 41 (10–96) | <0.001 |
Baseline DHEAS/cortisol ratio | 2.86 ± 1.40 | 0.92 ± 0.73 | 0.001 |
IL-6 (pg/ml) | 110 (54–233) | 571 (247.25–924) | 0.004 |
TNF-α (pg/ml) | 10 (5.5–25) | 45.5 (31.25–78.25) | 0.001 |
Sensitivity | Specificity | PPV | NPV | Accuracy | |
---|---|---|---|---|---|
DHEAS | 0.818 | 0.647 | 0.429 | 0.917 | 0.689 |
DHEAS/cortisol | 0.909 | 0.842 | 0.625 | 0.966 | 0.844 |
High DHEAS/cortisol ratio (>1.50) (n = 17) | Low DHEAS/cortisol ratio (<1.50) (n = 29) |
p value | |
---|---|---|---|
Age (years) | 48.7 ± 11.4 | 60.2 ± 15.2 | 0.010 |
Gender (M/F) | 15/2 | 21/8 | 0.282 |
Hospital mortality | 6/17 (35.3%) | 28/29 (96.6%) | <0.001 |
SOFA score | 10.8 ± 4.5 | 13.6 ± 3.7 | 0.030 |
MELD score | 26.1 ± 12.7 | 32.1 ± 10.0 | 0.082 |
Child–Pugh score | 12 (8–12.5) | 12 (11–13.5) | 0.106 |
ACTH (pg/ml) | 19 (7.8–27.2) | 20.4 (10.8–38) | 0.372 |
Baseline cortisol (nmol/L) | 441 (382–691) | 910 (661–1422) | 0.001 |
Peak cortisol (nmol/L) | 822 (608–1141) | 1048 (902–1671) | 0.006 |
Cortisol increment (nmol/L) | 273 (189–403) | 196 (97–288) | 0.037 |
Baseline DHEAS (nmol/L) | 1099 (885–2124) | 551 (362–769) | <0.001 |
Peak DHEAS (nmol/L) | 1286 (974–2546) | 643 (360–1057) | <0.001 |
DHEAS increment (nmol/L) | 135.7 (88.2–248.3) | 35.3 (6.8–118.1) | 0.009 |
IL-6 (pg/ml) | 198 (58.5–444) | 571 (221–1012) | 0.025 |
TNF-α (pg/ml) | 17.6 (8.4–32.3) | 47.5 (30–96.8) | 0.002 |
CIRCI | 7/17 (41.2%) | 21/29 (72.4%) | 0.036 |
CIRCI (n = 28) | Non-CIRCI (n = 18) |
p value | |
---|---|---|---|
Age (years) | 56.0 ± 12.8 | 56.0 ± 18.0 | 0.997 |
Gender (M/F) | 22/6 | 14/4 | 1.000 |
SOFA score | 14.8 ± 3.3 | 8.7 ± 2.8 | <0.001 |
MELD score | 35.3 ± 8.8 | 21.3 ± 9.5 | <0.001 |
Child–Pugh score | 13 (12–14) | 9 (8–11.5) | <0.001 |
ACTH (pg/ml) | 28 (15–40) | 7.9 (6.7–18.3) | <0.001 |
Baseline cortisol (nmol/L) | 877 (481–1331) | 555 (417–859) | 0.054 |
Peak cortisol (nmol/L) | 967 (695–1505) | 1021 (803–1458) | 0.727 |
Cortisol increment (nmol/L) | 145 (70–217) | 399 (314–546) | <0.001 |
Baseline DHEAS (nmol/L) | 678 (437–1111) | 921 (524–1552) | 0.229 |
Peak DHEAS (nmol/L) | 750 (491–1141) | 1159 (595–1866) | 0.075 |
DHEAS increment (nmol/L) | 41 (16–101) | 180 (90–278) | 0.002 |
Baseline DHEAS/cortisol | 1.01 ± 0.79 | 2.11 ± 1.58 | 0.012 |
IL-6 (pg/ml) | 660 (240–968) | 164 (85–328) | 0.011 |
TNF-α (pg/ml) | 44 (31–79) | 16 (6–36) | 0.007 |
Hospital mortality | 26/28 (92.9%) | 8/18 (44.4%) | <0.001 |
Comparison between patients with septic shock with and without liver cirrhosis
Liver cirrhosis (n = 46) | Nonliver cirrhosis (n = 46) |
p value | |
---|---|---|---|
Age (years) | 56.0 ± 14.9 | 58.1 ± 20.5 | 0.556 |
Gender (M/F) | 36/10 | 36/10 | 1.000 |
SOFA score | 12.7 ± 4.1 | 6.7 ± 4.1 | <0.001 |
Baseline cortisol (nmol/L) | 748 (450–1203) | 778 (590–1109) | 0.628 |
Peak cortisol (nmol/L) | 993 (744–1479) | 1195 (948–1589) | 0.041 |
Cortisol increment (nmol/L) | 221 (121–348) | 408 (285–570) | <0.001 |
ACTH (pg/ml) | 19.1 (9.1–34.0) | 20.3 (8–30.5) | 0.842 |
Baseline DHEAS (nmol/L) | 703 (464–1180) | 842 (587–1432) | <0.001 |
Peak DHEAS (nmol/L) | 939 (497–1296) | 1037 (643–1752) | <0.001 |
DHEAS increment (nmol/L) | 89.6 (23–185) | 325.7 (174–546) | <0.001 |
Baseline DHEAS/cortisol | 1.40 ± 1.24 | 3.86 ± 2.57 | 0.001 |
IL-6 (pg/ml) | 424 (206–855) | 88 (35–275) | 0.002 |
TNF-α (pg/ml) | 34 (21–70) | 15 (10.65–23.5) | 0.003 |
Hospital mortality | 34/46 (73.9%) | 16/46 (34.8%) | <0.001 |
Comparison between male and female patients with liver cirrhosis
Male (n = 36) | Female (n = 10) |
p value | |
---|---|---|---|
Age (years) | 52.9 ± 12.6 | 67.0 ± 17.9 | 0.007 |
Hospital mortality | 25/36 (69.4%) | 9/10 (90%) | (0.252) |
SOFA score | 12.2 ± 4.4 | 13.0 ± 4.2 | (0.618) |
MELD score | 30.5 (24–39.8) | 27 (16.8–37.8) | (0.431) |
Child–Pugh score | 12 (10.3–13) | 11.5 (9–13.3) | (0.666) |
ACTH (pg/ml) | 19.1 (9.8–32.7) | 22 (6.3–47.9) | (0.929) |
Baseline cortisol (nmol/L) | 675 (428–1086) | 975 (680–1260) | (0.132) |
Peak cortisol (nmol/L) | 927 (697–1381) | 1338 (955–1639) | (0.088) |
Cortisol increment (nmol/L) | 221 (112–353) | 240 (167–466) | (0.432) |
Baseline DHEAS (nmol/L) | 704 (437–1140) | 824 (510–1428) | (0.409) |
Peak DHEAS (nmol/L) | 877 (491–1263) | 961 (510–1692) | (0.489) |
DHEAS increment (nmol/L) | 89.6 (25.8–171.7) | 70.6 (0–245.7) | (0.957) |
Baseline DHEAS/cortisol ratio | 1.46 ± 1.16 | 1.37 ± 1.68 | (0.843) |
IL-6 (pg/ml) | 318 (150–855) | 482 (310–1288) | (0.404) |
TNF-α (pg/ml) | 31 (11.2–78) | 47 (39–52.5) | (0.208) |
CIRCI | 22/36 (61.1%) | 6/10 (60%) | (1.000) |